Wayland Group Corp (MRRCF)
0.00
USD |
OTCM |
May 31, 16:00
Wayland Group Shareholders Equity (Quarterly): 74.29M for June 30, 2018
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 96.06M |
| June 30, 2018 | 74.29M |
| March 31, 2018 | 78.05M |
| December 31, 2017 | 48.92M |
| September 30, 2017 | 13.35M |
| June 30, 2017 | 15.91M |
| March 31, 2017 | -44.49M |
| December 31, 2016 | -2.400M |
| September 30, 2016 | -0.4045M |
| June 30, 2016 | -0.3977M |
| Date | Value |
|---|---|
| March 31, 2016 | -0.3841M |
| December 31, 2015 | -0.3364M |
| September 30, 2015 | -0.3322M |
| June 30, 2015 | -0.3473M |
| March 31, 2015 | -0.3054M |
| December 31, 2014 | -0.3221M |
| September 30, 2014 | -8.695M |
| June 30, 2014 | -8.874M |
| December 31, 2013 | -8.370M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| Liminal Biosciences Inc (DELISTED) | 16.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.53M |
| Total Liabilities (Quarterly) | 21.24M |